Anagin Seeks Restorative Therapies

December 16, 2016

Indiana University Scientists form Biotech Startup

Anagin is aware of the huge demand for effective brain therapies. Up until now, sufferers of Post Traumatic Stress Disorder and Traumatic Brain Injury, faced a pretty bleak prognosis. In a report by the Center of Disease Control, between 2002 to 2006 1.7 million people sustained a TBI. The Mayo Clinic defines TBI as “an external mechanical force [that] causes brain dysfunction. Traumatic brain injury usually results from a violent blow or jolt to the head or body. An object penetrating the skull, such as a bullet or shattered piece of skull.”
The largest percentage of those, 35.2 % were due to falls, and 17.35% motor vehicle related. This category is the leading cause of TBI deaths. The number rose considerably by 2010. About 2.5 million deaths, hospitalizations and emergency-room visits in the United States were associated with traumatic brain injury. A lengthy but informative article published on Brainline.com by Mount Sinai Medical Center states: “Individuals with a moderate-to-severe brain injury most typically experience problems in basic cognitive skills: sustaining attention, concentrating on tasks at hand, and remembering newly learned material.”

Populations at Risk

Anagin researchers seek PSTD and TBI relief

PSTD alone affects one in seven Americans. Cases consist of soldiers, fire fighters and police, plus domestic abuse, child abuse and sexual assault. While women are twice as likely to develop PSTD sometime in their future, little can be done to address the root cause. Symptoms like anxiety, depression, and addiction can be treated, but are not the root concern.
Anantha Shekhar, a practicing psychiatrist for nearly 30 years stated that about 40 percent of PTSD sufferers become “completely disabled” by its symptoms. One fifth of those become suicide risks and 60 percent develop drug or alcohol addictions. Although drug treatments may often work, the side effects may create other/additional problems.Correction and true healing usually fall outside the limits of currently available treatments.

Knowing that no effective treatment existed challenged Shekhar as a physician and a researcher.
Teaming up with another Indiana University scientist, Co-Founder Yvonne Lai Anagin. The team currently consists of business leaders and scientists with decades of experience. They feel a high level of commitment and responsibility regarding the discovery of cures that will drastically change lives.

While still early in their clinical trials, their goal is to “eliminate the persistence of the feelings the trauma produced.” Joe Trebley, who heads Spin Up, Indiana University’s nonprofit business accelerator focused on tech-driven businesses, said this: “For any sufferer of PTSD — veterans, domestic abuse victims, child abuse victims — the work that Anagin is doing will be a game changer.”

Anagin hopes their research will yield advancements for many issues affecting the brain. While PTSD and Traumatic Brain Injury top the list, they hope it is the catalyst for many more opportunities.
For more information visit National Center for PTSD. 

See the case study here.